STRATA Skin Sciences, Inc. (SSKN) intrinsic value & 10-year financials
STRATA Skin Sciences, Inc. (SSKN) has no Graham intrinsic value right now because the formula needs positive earnings. Over the last 10 fiscal years revenue shrank 0.4% a year to $30.7M, with an average return on invested capital of -24.2%.
- Graham intrinsic value
- —
- Share price (Oct 17, 2026)
- $0.00
- Market cap
- $930
- Revenue (FY2025)
- $30.7M
- Revenue growth (10-yr CAGR)
- -0.4%
- ROIC (10-yr avg)
- -24.2%
- Free cash flow (FY2025)
- -$4.3M
SSKN 10-year financial history
| Fiscal year | Revenue | Net income | EPS (diluted) | Free cash flow | Operating margin | ROIC |
|---|---|---|---|---|---|---|
| FY2025 | $30.7M | -$6.3M | -$1.35 | -$4.3M | -15.3% | -37.8% |
| FY2024 | $33.6M | -$10.1M | -$2.65 | -$1.4M | -27.6% | -52.0% |
| FY2023 | $33.4M | -$10.8M | -$0.31 | -$5.5M | -25.8% | -37.4% |
| FY2022 | $36.2M | -$5.5M | -$0.16 | -$4.7M | -12.9% | -20.7% |
| FY2021 | $30.0M | -$2.7M | — | -$2.1M | -14.7% | -22.5% |
| FY2020 | $23.1M | -$4.4M | -$0.13 | $2.1M | -17.7% | -20.3% |
| FY2019 | $31.6M | -$3.8M | -$0.11 | $2.1M | -9.5% | -13.2% |
| FY2018 | $29.9M | -$4.0M | -$0.15 | — | -11.2% | -12.5% |
| FY2017 | $31.8M | -$18.8M | -$0.41 | — | -7.6% | -9.5% |
| FY2016 | $31.8M | -$3.3M | -$0.11 | — | -11.3% | -16.2% |
Source: annual 10-K filings on SEC EDGAR. Figures in USD.
Executive summary
STRATA Skin Sciences, Inc. is facing top-line stagnation, with revenue contracting over the decade.
STRATA Skin Sciences, Inc. has historically struggled to out-earn its cost of capital, averaging just -24.2% ROIC.
Over the decade, STRATA Skin Sciences, Inc. shows that management has aggressively returned capital to shareholders by retiring 94.3% of outstanding shares.
Benjamin Graham lens
Under Benjamin Graham's formula using SEC EDGAR fundamentals, STRATA Skin Sciences, Inc. is modeled at -0.4% normalized earnings growth with a 5.1% bond-yield adjustment. The resulting Graham intrinsic value estimate is $-9.01 per share.